PAP
ANIP icon

Persistent Asset Partners’s ANI Pharmaceuticals ANIP Stock Holding History

Persistent Asset Partners’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.2K Buy
+920
New +$73.8K 0.02% 345
2026
Q1 		– Sell
-14,320
Closed -$1.13M – 334
2025
Q4 		$1.13M Buy
14,320
+7,112
+99% +$616K 0.51% 52
2025
Q3 		$660K Buy
+7,208
New +$588K 0.45% 71

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Persistent Asset Partners's ANIP Position: Q2 2026 in Review

Persistent Asset Partners opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 920 shares worth $76.2K. The stake represents 0.02% of the portfolio and ranks #345 among its holdings. This is a return to the name: Persistent Asset Partners previously reported a position in ANIP as recently as Q4 2025.

Persistent Asset Partners first reported a position in ANIP in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.13M in Q4 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Persistent Asset Partners held 920 shares of ANI Pharmaceuticals worth $76.2K as of Q2 2026.
  • ANI Pharmaceuticals was a new Persistent Asset Partners position in Q2 2026.
  • ANI Pharmaceuticals made up 0.02% of Persistent Asset Partners's portfolio in Q2 2026, its #345 holding.
  • Persistent Asset Partners first reported a position in ANI Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Persistent Asset Partners's ANI Pharmaceuticals position peaked at $1.13M in Q4 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.